Delivery Order SPE2DB20D2104-SPE2DB25FMHEM

Award Date 2/3/25
Potential Completion Date 2/4/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $38,549.15, is a Firm Fixed Price Delivery Order for the supply of 4,562,688 units of Ropinirole HCL 1 mg tablets. The ultimate completion date for this order is November 3, 2023. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ropinirole HCL ER 2 mg tablets, a medication used to treat Parkinson's disease. The award has a ceiling value of $7,780.64 and an ultimate completion date of January 13, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, identified as SPE2DX15D2205|SPE2DX24F74RL, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,235.59, is for the delivery of 90 tablets of the prescription drug Ropinirole HCL ER 2 mg. This is a Firm Fixed Price Delivery Order contract with a completion date of November 24, 2023. The contract was not designated as a...
This federal contract award, valued at $4,917.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company. The contract is for the delivery of Ropinirole HCL ER 8 mg tablets, a medication used to treat Parkinson's disease. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. The contract does not have a set-aside designation, indicating it was awarded...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of 4 milligram Ropinirole Hydrochloride extended-release tablets, a generic medication used to treat Parkinson's disease. The ceiling value of the delivery order is $3,345.60 and the ultimate completion date is December...
The Defense Logistics Agency Troop Support Medical awarded a $8,180 delivery order to Amerisourcebergen Drug Corporation for 4562279910 Ropinirole HCL 4 MG tablets. The firm fixed price order is for 100 count bottles of the pharmaceutical product, to be delivered to Amerisourcebergen's facility in Conshohocken, Pennsylvania by September 25, 2023. No additional details were provided regarding the original solicitation or whether this delivery order is associated with any broader indefinite...
The Defense Logistics Agency awarded a $105,450 delivery order to AmerisourceBergen Drug Corporation for the supply of 4561504241 Ropinirole HCL 1 MG tablets. Under this firm fixed price contract, AmerisourceBergen will deliver 100 count bottles of the generic Parkinson's disease medication to a facility in Conshohocken, Pennsylvania by July 17, 2023 in support of the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were identified. The delivery...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at twenty-eight thousand one hundred fourteen dollars to Amerisourcebergen Drug Corporation for 4561441401 Ropinirole HCL 0.5 MG Tablets (100 count). Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania, spanning from July 9th through the 10th of 2023. No set aside designation or subcontracting details were provided. This order is likely placed against DLA's Pharmaceutical Prime Vendor...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,035.66 firm fixed-price delivery order is for 4564898835 REXULTI 1 MG TABLET 30S, a pharmaceutical product. The contract has a completion date of June 14, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,737.88 contract is for the supply of 250 mcg roflumilast tablets, which are used to treat respiratory conditions. The order has a performance period through December 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a broad range of pharmaceuticals and...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMHEM
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,593.30, is for the delivery of ropinirole HCL ER 8 mg tablets. This is a firm-fixed-price delivery order contract with a completion date of February 4, 2025. The contract is not designated as a set-aside.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/5/25, 9:42 AM